NA
HZNP

NewEdge Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

NewEdge Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-800
Closed -$92.6K – 3929
2023
Q3 		$92.6K Sell
800
-454
-36% -$48.8K ﹤0.01% 1864
2023
Q2 		$129K Buy
1,254
+206
+20% +$21.7K ﹤0.01% 1773
2023
Q1 		$114K Sell
1,048
-446
-30% -$49.3K ﹤0.01% 1702
2022
Q4 		$56.3K Sell
1,494
-5,525
-79% -$459K ﹤0.01% 1671
2022
Q3 		$434K Sell
7,019
-910
-11% -$63.6K 0.01% 1037
2022
Q2 		$632K Buy
+7,929
New +$751K 0.01% 878
2022
Q1 		– Sell
-8,340
Closed -$899K – 1729
2021
Q4 		$899K Sell
8,340
-2,510
-23% -$274K 0.01% 787
2021
Q3 		$1.19M Buy
10,850
+425
+4% +$44.1K 0.03% 464
2021
Q2 		$976K Buy
10,425
+6,275
+151% +$577K 0.03% 501
2021
Q1 		$382K Buy
4,150
+29
+0.7% +$2.45K 0.01% 736
2020
Q4 		$301K Buy
4,121
+565
+16% +$42K 0.01% 761
2020
Q3 		$276K Buy
+3,556
New +$245K 0.01% 738
2020
Q1 		– Sell
-8,253
Closed -$298K – 929
2019
Q4 		$298K Sell
8,253
-377
-4% -$11.6K 0.01% 662
2019
Q3 		$235K Sell
8,630
-940
-10% -$24.3K 0.01% 703
2019
Q2 		$230K Buy
9,570
+109
+1% +$2.77K 0.01% 587
2019
Q1 		$250K Buy
+9,461
New +$224K 0.02% 572

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

NewEdge Advisors's HZNP Position: Q4 2023 in Review

NewEdge Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 800 shares — an estimated $92.6K sold.

NewEdge Advisors first reported a position in HZNP in Q1 2019 and held it in 16 quarters. The position peaked at $1.19M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • NewEdge Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • NewEdge Advisors sold 800 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $92.6K.
  • NewEdge Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 16 quarters.
  • NewEdge Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.19M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on NewEdge Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.